Therefore, functional inhibition of pDCs through BDCA2 ligation in the absence of pDC depletion is a unique approach that could lead to both efficacy and a better safety profile in autoimmune diseases such as SLE. This evidence concerns the gene CLEC4C and systemic lupus erythematosus.